Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Saturday, September 6, 2008, 4:35PM ET - U.S. Markets Closed. Dow Up 0.29% Nasdaq Down 0.14%
Micrus Endovascular Corp. (MEND)On Sep 5: 12.59  Up 0.14 (1.12%)  
MORE ON MEND
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Micrus Endovascular Corp.
821 Fox Lane
San Jose, CA 95131
United States - Map
Phone: 408-433-1400
Fax: 408-433-1401
Web Site: http://www.micruscorp.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:318

BUSINESS SUMMARY 
Micrus Endovascular Corporation engages in the development, manufacture, and marketing of implantable and disposable medical devices used in the treatment of cerebral vascular diseases. It offers microcoil products, such as MicruSphere microcoil, a three-dimensional framing microcoil for stabilizing the aneurysm; Presidio microcoil, a framing and filling coil to deliver neck and wall coverage in a single deployment; Cashmere complex microcoil, a three-dimensional framing and filling complex coil for aneurysms that requires a softer coil; UltiPaq microcoil, a finishing microcoil designed to complete filling of the aneurysm; HeliPaq HeliPaq SR and InterPaq microcoils, which are filling microcoils that occlude aneurysm following framing; and Cerecyte microcoils, which include filaments comprised of polyglycolic acid, a bioactive material. The company also offers access products, such as Courier ENZO and Courier microcatheters, which are deflectable devices used to deliver embolic into the aneurysm; and Watusi guidewire, a device used to guide microcatheters and other devices to the aneurysm or stenosis site. In addition, it provides PHAROS balloon-expandable stent system, which is used for scaffolding wide-neck aneurysms to ensure that the microcoil is not dislodged, as well as for opening intracranial arteries that have narrowed; and EnPower detachment control box and connecting cable, which is a control box to provide electronic control via a lithium ion battery and initiates detachment of proprietary microcoil system. The company’s products are used by interventional neuroradiologists, interventional neurologists, and neurosurgeons. It sells its products through direct sales force in the United States, Canada, the United Kingdom, Germany, Austria, and France; and through a network of distributors in the rest of Europe, Latin America, Asia, and the Middle East. The company, formerly Micrus Corporation, was founded in 1996 and is headquartered in San Jose, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Micrus Endovascular Corp.


    CORPORATE GOVERNANCE 
    Micrus Endovascular Corp.'s Corporate Governance Quotient (CGQ®) as of 1-Sep-08 is better than 17.5% of Russell 3000 companies and 26.5% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. John T. Kilcoyne , 48
    Exec. Chairman and Chief Exec. Officer
    N/A N/A
    Mr. Robert A. Stern , 50
    Pres, Chief Operating Officer and Sec.
    N/A N/A
    Mr. Gordon T. Sangster , 55
    Chief Financial Officer and Chief Accounting Officer
    N/A N/A
    Mr. Edward F. Ruppel Jr., 41
    VP of Technical Operations and Corp. Compliance Officer
    N/A N/A
    Mr. Robert C. Colloton , 49
    VP of Global Sales & Marketing
    N/A N/A
    Dollar amounts are as of and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis